Acorda Therapeutics
ACOR
$0.66
Share price
0.00%
Change (1 day)
27.12%
Change (1 year)
Categories
Acorda Therapeutics (ACOR) - Total debt
Total debt on the balance sheet as of September 2023 : $0.18 B
According to Acorda Therapeutics 's latest financial reports the company's total debt is $0.18 B. A company’s total debt is the sum of all current and non-current debts.
Acorda Therapeutics - Total debt on balance sheet (from 2003 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.17 B | -9.44% |
| 2021-12-31 | $0.19 B | -26.55% |
| 2020-12-31 | $0.25 B | 4.14% |
| 2019-12-31 | $0.24 B | -27.39% |
| 2018-12-31 | $0.34 B | 2.58% |
| 2017-12-31 | $0.33 B | 1.23% |
| 2016-12-31 | $0.33 B | 13.1% |
| 2015-12-31 | $0.29 B | 0.57% |
| 2014-12-31 | $0.29 B | 6556.61% |
| 2013-12-31 | $4.37 M | -18.86% |
| 2012-12-31 | $5.38 M | -15.47% |
| 2011-12-31 | $6.37 M | -17.44% |
| 2010-12-31 | $7.72 M | -0.37% |
| 2009-12-31 | $7.74 M | 7% |
| 2008-12-31 | $7.24 M | 5.1% |
| 2007-12-31 | $6.89 M | -10.96% |
| 2006-12-31 | $7.73 M | -29.53% |
| 2005-12-31 | $10.98 M | 23.84% |
| 2004-12-31 | $8.86 M | 5.39% |
| 2003-12-31 | $8.41 M | |
| 2003-06-30 | $8.82 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | $1.39 B | 650.61% | 🇺🇸 USA |
 Repligen
RGEN | $0.71 B | 282.51% | 🇺🇸 USA |
 Affimed
AFMD | $22.26 M | -88.03% | 🇩🇪 Germany |
 BioMarin Pharmaceutical BMRN | $1.09 B | 488.83% | 🇺🇸 USA |